Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2026-03-10 @ 7:27 PM
Study NCT ID:
NCT05421806
Status:
COMPLETED
Last Update Posted:
2023-09-26
First Post:
2022-06-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/
Sponsor:
NEAT ID Foundation
Organization:
Study Overview
Official Title:
A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe
Status:
COMPLETED
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DrEW
Brief Summary:
Following the initiation of Doravirine (DOR) regimen among people living with HIV (PLWH), the study will aim to assess effectiveness, discontinuation, and resistance over the 12-month period.
Retrospective data from 400 patients, 100 treatment naïve and 300 virally suppressed patients switching from a 1st or second line treatment, is planned to be collected from 6 - 10 European sites.
The study will be conducted through collaboration with the NEAT ID Network, a well-established network of clinical sites across Europe.
Retrospective data from 400 patients, 100 treatment naïve and 300 virally suppressed patients switching from a 1st or second line treatment, is planned to be collected from 6 - 10 European sites.
The study will be conducted through collaboration with the NEAT ID Network, a well-established network of clinical sites across Europe.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| NEAT 1010 | OTHER | NEAT ID | View |